Abstract
ForI is a PLP-dependent enzyme from the biosynthetic pathway of the C-nucleoside antibiotic formycin. Cycloserine is thought to inhibit PLP-dependent enzymes by irreversibly forming a PMP–isoxazole. We now report that ForI forms novel PMP–diketopiperazine derivatives following incubation with both d and l cycloserine. This unexpected result suggests chemical diversity in the chemistry of cycloserine inhibition.
| Original language | English |
|---|---|
| Pages (from-to) | 14502-14505 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 55 |
| Issue number | 96 |
| Early online date | 15 Nov 2019 |
| DOIs | |
| Publication status | Published - 14 Dec 2019 |
Fingerprint
Dive into the research topics of 'PMP–diketopiperazine adducts form at the active site of a PLP dependent enzyme involved in formycin biosynthesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver